Jad Sfeir

1.9k total citations · 2 hit papers
34 papers, 1.3k citations indexed

About

Jad Sfeir is a scholar working on Orthopedics and Sports Medicine, Nephrology and Oncology. According to data from OpenAlex, Jad Sfeir has authored 34 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Orthopedics and Sports Medicine, 8 papers in Nephrology and 8 papers in Oncology. Recurrent topics in Jad Sfeir's work include Bone health and osteoporosis research (10 papers), Bone health and treatments (8 papers) and Parathyroid Disorders and Treatments (8 papers). Jad Sfeir is often cited by papers focused on Bone health and osteoporosis research (10 papers), Bone health and treatments (8 papers) and Parathyroid Disorders and Treatments (8 papers). Jad Sfeir collaborates with scholars based in United States, Singapore and Lebanon. Jad Sfeir's co-authors include Matthew T. Drake, Sundeep Khosla, Joshua N. Farr, Robert J. Pignolo, Tamar Tchkonia, David G. Monroe, James L. Kirkland, Nathan K. LeBrasseur, Tamar Pirtskhalava and Christine Hachfeld and has published in prestigious journals such as Nature Medicine, The Journal of Clinical Endocrinology & Metabolism and BMJ.

In The Last Decade

Jad Sfeir

32 papers receiving 1.3k citations

Hit Papers

Targeting cellular senescence prevents age-related bone l... 2017 2026 2020 2023 2017 2024 250 500 750
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Targeting cellular senescence prevents age-related bone loss in mice
    2017 819 citations Joshua N. Farr, David G. Monroe et al. Nature Medicine profile →
  2. Effects of intermittent senolytic therapy on bone metabolism in postmenopausal women: a phase 2 randomized controlled trial
    2024 46 citations Joshua N. Farr, Elizabeth J. Atkinson et al. Nature Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jad Sfeir United States 13 510 494 214 192 156 34 1.3k
Sabrina Gohlke Germany 12 482 0.9× 354 0.7× 90 0.4× 168 0.9× 152 1.0× 16 1.1k
Yanqiu Wang China 19 482 0.9× 167 0.3× 67 0.3× 85 0.4× 67 0.4× 57 1.2k
Michaela Tencerová Czechia 27 740 1.5× 865 1.8× 287 1.3× 440 2.3× 254 1.6× 55 2.4k
Zoë Urry United Kingdom 13 570 1.1× 312 0.6× 252 1.2× 359 1.9× 221 1.4× 17 1.5k
Saverio Loddo Italy 24 400 0.8× 205 0.4× 83 0.4× 172 0.9× 172 1.1× 59 1.3k
Ken-ichiro Tanaka Japan 19 500 1.0× 218 0.4× 301 1.4× 83 0.4× 182 1.2× 35 1.1k
Ruth Álvarez Spain 21 324 0.6× 194 0.4× 70 0.3× 66 0.3× 201 1.3× 38 1.3k
Luigi Aurelio Nasto Italy 20 344 0.7× 215 0.4× 59 0.3× 99 0.5× 45 0.3× 78 1.7k
Lingyun Lu China 16 480 0.9× 105 0.2× 134 0.6× 95 0.5× 116 0.7× 45 964
Kazuya Oshima Japan 14 416 0.8× 751 1.5× 184 0.9× 219 1.1× 193 1.2× 42 1.9k

Countries citing papers authored by Jad Sfeir

Since Specialization
Citations

This map shows the geographic impact of Jad Sfeir's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jad Sfeir with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jad Sfeir more than expected).

Fields of papers citing papers by Jad Sfeir

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jad Sfeir. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jad Sfeir. The network helps show where Jad Sfeir may publish in the future.

Co-authorship network of co-authors of Jad Sfeir

This figure shows the co-authorship network connecting the top 25 collaborators of Jad Sfeir. A scholar is included among the top collaborators of Jad Sfeir based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jad Sfeir. Jad Sfeir is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Saul, Dominik, et al.. (2025). Advances in the management of osteoporosis. BMJ. 390. e081250–e081250. 4 indexed citations
2.
Sfeir, Jad, et al.. (2025). Gallium-68-DOTATATE PET/CT for phosphaturic mesenchymal tumor localization in suspected tumor-induced osteomalacia. JBMR Plus. 9(5). ziaf040–ziaf040. 1 indexed citations
3.
Sfeir, Jad, et al.. (2024). Statin-Induced Necrotizing Autoimmune Myopathy: Diagnosis and Treatment Approach. JCEM Case Reports. 2(12). luae227–luae227. 1 indexed citations
4.
Farr, Joshua N., Elizabeth J. Atkinson, Sara J. Achenbach, et al.. (2024). Effects of intermittent senolytic therapy on bone metabolism in postmenopausal women: a phase 2 randomized controlled trial. Nature Medicine. 30(9). 2605–2612. 46 indexed citations breakdown →
5.
Sfeir, Jad, et al.. (2024). A Retrospective Cohort of Tumor-Induced Osteomalacia and Case Series of Malignant Disease. The Journal of Clinical Endocrinology & Metabolism. 110(2). e397–e411. 5 indexed citations
6.
7.
Hanna, Christian, Byron H. Smith, Charles D. Madsen, et al.. (2023). Bone health in autosomal dominant polycystic kidney disease (ADPKD) patients after kidney transplantation. Bone Reports. 18. 101655–101655. 3 indexed citations
8.
Sfeir, Jad, et al.. (2023). Cardiovascular benefits and risks associated with calcium, vitamin D, and antiresorptive therapy in the management of skeletal fragility. Women s Health. 19. 902580747–902580747. 3 indexed citations
9.
Saul, Dominik, Lei Zhang, Zaira Aversa, et al.. (2023). In vitro and in vivo effects of zoledronic acid on senescence and senescence-associated secretory phenotype markers. Aging. 15(9). 3331–3355. 24 indexed citations
10.
Sfeir, Jad, Matthew T. Drake, Sundeep Khosla, & Joshua N. Farr. (2022). Skeletal Aging. Mayo Clinic Proceedings. 97(6). 1194–1208. 65 indexed citations
11.
Benson, John C., Jorge Trejo‐Lopez, Ashley M. Nassiri, et al.. (2022). Phosphaturic Mesenchymal Tumor. American Journal of Neuroradiology. 43(6). 817–822. 12 indexed citations
12.
Sfeir, Jad & Robert J. Pignolo. (2021). Pharmacologic Interventions for Fracture Risk Reduction in the Oldest Old: What Is the Evidence?. JBMR Plus. 5(10). e10538–e10538. 9 indexed citations
13.
Björnsdóttir, Sigríður, Steven Ing, Deborah M. Mitchell, et al.. (2020). Epidemiology and Financial Burden of Adult Chronic Hypoparathyroidism. Journal of Bone and Mineral Research. 37(12). 2602–2614. 24 indexed citations
14.
15.
Sfeir, Jad, et al.. (2019). Vertebral compression fractures associated with yoga: a case series. European Journal of Physical and Rehabilitation Medicine. 54(6). 947–951. 11 indexed citations
16.
17.
Yasmin, Mohamad, et al.. (2017). A 27-year experience with infective endocarditis in Lebanon. Journal of Infection and Public Health. 10(6). 734–739. 7 indexed citations
18.
Kanafani, Zeina A., Sukayna Fadlallah, Kohar Annie B. Kissoyan, et al.. (2017). Sites of colonization in hospitalized patients with infections caused by extended-spectrum beta-lactamase organisms: a prospective cohort study. Antimicrobial Resistance and Infection Control. 6(1). 46–46. 3 indexed citations
19.
Sfeir, Jad, Matthew T. Drake, Betsy LaPlant, et al.. (2017). Validation of a vitamin D replacement strategy in vitamin D-insufficient patients with lymphoma or chronic lymphocytic leukemia. Blood Cancer Journal. 7(2). e526–e526. 14 indexed citations
20.
Ballane, Ghada, Jad Sfeir, Habib A. Dakik, Edward M. Brown, & Ghada El‐Hajj Fuleihan. (2012). Use of recombinant human parathyroid hormone in hypocalcemic cardiomyopathy. European Journal of Endocrinology. 166(6). 1113–1120. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sabrina Gohlke Breakdown of academic impact, for papers by Yanqiu Wang Breakdown of academic impact, for papers by Michaela Tencerová Breakdown of academic impact, for papers by Zoë Urry Breakdown of academic impact, for papers by Saverio Loddo Breakdown of academic impact, for papers by Ken-ichiro Tanaka Breakdown of academic impact, for papers by Ruth Álvarez Breakdown of academic impact, for papers by Luigi Aurelio Nasto Breakdown of academic impact, for papers by Lingyun Lu Breakdown of academic impact, for papers by Kazuya Oshima
Rankless by CCL
2026